Rizzardini G - Search Results

1

Darunavir/cobicistat for the treatment of HIV-1: a new era for compact drugs with high genetic barrier to resistance.

Capetti A, Cossu MV, Rizzardini G. Capetti A, et al. Among authors: rizzardini g. Expert Opin Pharmacother. 2015;16(17):2689-702. doi: 10.1517/14656566.2015.1109632. Epub 2015 Nov 27. Expert Opin Pharmacother. 2015. PMID: 26612518 Review.

2

[Primary treatment of cryptococcosis in AIDS: itraconazole in single dose or combined with 5-fluorocytosine].

Fasan M, Gubertini G, Cargnel A, Vigevani GM, Rizzardini G, Capetti A, Vaglia A, Grancini A, Malaspina C, Tortorano AM, et al. Fasan M, et al. Among authors: rizzardini g. G Ital Chemioter. 1991 Jan-Dec;38(1-3):199-200. G Ital Chemioter. 1991. PMID: 1365593 Clinical Trial. Italian. No abstract available.

3

Lipid-based amphotericin B in the treatment of cryptococcosis.

Viviani MA, Rizzardini G, Tortorano AM, Fasan M, Capetti A, Roverselli AM, Gringeri A, Suter F. Viviani MA, et al. Among authors: rizzardini g. Infection. 1994 Mar-Apr;22(2):137-42. doi: 10.1007/BF01739025. Infection. 1994. PMID: 7915255

4

Virological treatment failure of highly active antiretroviral therapy in an unselected cohort of HIV-infected patients.

Bonfanti P, Capetti A, Di Mattei P, Niero F, Rizzardini G. Bonfanti P, et al. Among authors: rizzardini g. AIDS. 1998 Jun 18;12(9):1111. AIDS. 1998. PMID: 9662213 No abstract available.

5

HIV disease treatment in the era of HAART.

Bonfanti P, Capetti A, Rizzardini G. Bonfanti P, et al. Among authors: rizzardini g. Biomed Pharmacother. 1999 Mar;53(2):93-105. doi: 10.1016/s0753-3322(99)80066-3. Biomed Pharmacother. 1999. PMID: 10337464 Free article. Review.

6

Simplification of protease inhibitor-containing regimens with efavirenz, nevirapine or abacavir: safety and efficacy outcomes.

Chiesa E, Bini T, Adorni F, Capetti A, Rizzardini G, Faggion I, Mussini C, Sollima S, Melzi S, Bongiovanni M, Tordato F, Cicconi P, Castelnuovo B, Rusconi S, d'Arminio Monforte A. Chiesa E, et al. Among authors: rizzardini g. Antivir Ther. 2003 Feb;8(1):27-35. Antivir Ther. 2003. PMID: 12713061

7

Drop in plasma lithium levels in 2 patients on concomitant boosted protease inhibitor regimens.

Capetti A, Landonio S, Faggion I, Rizzardini G. Capetti A, et al. Among authors: rizzardini g. J Int Assoc Physicians AIDS Care (Chic). 2006 Sep;5(3):119-20. doi: 10.1177/1545109706288799. J Int Assoc Physicians AIDS Care (Chic). 2006. PMID: 16928881 No abstract available.

8

Switch to abacavir-based triple nucleoside regimens in HIV-1 infected patients never treated with suboptimal antiretroviral therapy: a review.

Rizzardini G, Capetti A. Rizzardini G, et al. Med Sci Monit. 2006 Dec;12(12):RA269-276. Epub 2006 Nov 23. Med Sci Monit. 2006. PMID: 17136016 Review.

9

An immunological comparison of third companion in advanced drug-naive HIV-infected patients.

Rizzardini G, Trabattoni D, Capetti A, Castelletti E, Migliorino M, Panebianco R, Pacei M, Quirino T, Clerici M. Rizzardini G, et al. HIV Clin Trials. 2006 Sep-Oct;7(5):221-8. doi: 10.1310/hct0705-221. HIV Clin Trials. 2006. PMID: 17162315 Clinical Trial.

10

Late HIV seroconversion after non-occupational postexposure prophylaxis against HIV with concomitant hepatitis C virus seroconversion.

Terzi R, Niero F, Iemoli E, Capetti A, Coen M, Rizzardini G. Terzi R, et al. Among authors: rizzardini g. AIDS. 2007 Jan 11;21(2):262-3. doi: 10.1097/QAD.0b013e328011922c. AIDS. 2007. PMID: 17197828 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

435 results

Search Page

Filters